Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy-Reference-Cited by-同舟云学术

Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy

Published:2015-07 Issue:8 Volume:8 Page:1075-1083
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Cho Jung Rae,Rollini Fabiana,Franchi Francesco,DeGroat Christopher,Bhatti Mona,Dunn Elizabeth C.,Ferrante Elisabetta,Muniz-Lozano Ana,Suryadevara Siva,Zenni Martin M.,Guzman Luis A.,Bass Theodore A.,Angiolillo Dominick J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;J Am Coll Cardiol,2014

2. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;J Am Coll Cardiol,2011

3. 2014 ESC/EACTS Guidelines on myocardial revascularization

4. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation;van Giezen;J Thromb Haemost,2009

5. Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist;Capodanno;Expert Rev Cardiovasc Ther,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation;Frontiers in Cardiovascular Medicine;2022-11-22

2. Modern Antiplatelet Therapy: When Is Clopidogrel the Right Choice?;Cardiovascular Innovations and Applications;2018-07-01

3. Optimization of Antiplatelet Therapy in STEMI;Current Treatment Options in Cardiovascular Medicine;2017-08

4. In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Ticagrelor-Treated Patients;JACC: Cardiovascular Interventions;2017-07

5. Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study;Thrombosis and Haemostasis;2017